Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 78.29 million compared to CNY 99.82 million a year ago. Revenue was CNY 78.29 million compared to CNY 99.82 million a year ago.

Net loss was CNY 30.25 million compared to CNY 15.13 million a year ago. Basic loss per share from continuing operations was CNY 0.2484 compared to CNY 0.1242 a year ago. Diluted loss per share from continuing operations was CNY 0.2484 compared to CNY 0.1242 a year ago.